Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer's disease. - Qiu, Yuqi; Jacobs, Diane M.; Messer, Karen; Salmon, David P.; Wellington, Cheryl L.; Stukas, Sophie; Revta, Carolyn; Brewer, James B.; Léger, Gabriel C.; Askew, Brianna; Donahue, Lia; Kaplita, Stephen; et al. (Alzheimer's Research & Therapy, 2025)